Article

CVS Health to Present at the Jefferies 2015 Global Consumer Conference

CVS Health Corporation today announced that Helena Foulkes, executive vice president and president of CVS/pharmacy, will be speaking to investors at the Jefferies 2015 Global Consumer Conference.

PRESS RELEASE

WOONSOCKET, R.I.

,

June 12, 2015

/PRNewswire/ -- CVS Health Corporation (NYSE:

CVS

) today announced that

Helena Foulkes

, executive vice president and president of CVS/pharmacy, will be speaking to investors at the Jefferies 2015 Global Consumer Conference on

June 23, 2015

, at approximately

10:30 a.m. EDT

.

An audio webcast of the presentation will be broadcast simultaneously through the Investor Relations portion of the CVS Health website for all interested parties. To access the webcast, visit

http://investors.cvshealth.com

. This webcast will be archived and available on the website for a one-year period following the presentation.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its 7,800 retail pharmacies, nearly 1,000 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at

www.cvshealth.com

.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com